Literature DB >> 17287588

Effects of some H1-antagonists on the sleep-wake cycle in sleep-disturbed rats.

Shin Tokunaga1, Yasuhiro Takeda, Kazuaki Shinomiya, Masahiro Hirase, Chiaki Kamei.   

Abstract

The present study was undertaken to investigate the effects of some H(1)-antagonists on the sleep-wake cycle in sleep-disturbed rats in comparison with those of nitrazepam. Electrodes were chronically implanted into the frontal cortex and the dorsal neck muscle of rats for the electroencephalogram (EEG) and electromyogram (EMG), respectively. EEG and EMG were recorded with an electroencephalograph. SleepSign ver. 2.0 was used for EEG and EMG analysis. The total times of waking, non-rapid eye movement (non-REM), and rapid eye movement (REM) sleep were measured from 10:00 to 16:00. Nitrazepam showed a significant decrease in sleep latency, total waking time, and delta activity and an increase in the total non-REM sleep time. A significant decrease in the sleep latency was observed with diphenhydramine, chlorpheniramine, and cyproheptadine. Cyproheptadine also caused a significant decrease in the total waking time and increases in total non-REM sleep time, REM sleep time, slow wave sleep, and delta activity, although no remarkable effects were observed with diphenhydramine and chlorpheniramine. In conclusion, cyproheptadine can be useful as a hypnotic, having not only sleep inducing-effects, but also sleep quantity- and quality-increasing effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287588     DOI: 10.1254/jphs.fp0061173

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  9 in total

1.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

2.  The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?

Authors:  Trevor R Norman
Journal:  Psychopharmacology (Berl)       Date:  2012-02-15       Impact factor: 4.530

3.  Sleep physiology, abnormal States, and therapeutic interventions.

Authors:  Alvah T Wickboldt; Alex F Bowen; Aaron J Kaye; Adam M Kaye; Franklin Rivera Bueno; Alan D Kaye
Journal:  Ochsner J       Date:  2012

4.  Neuropharmacology of Sleep and Wakefulness: 2012 Update.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2012-09-04

5.  Induction of prolonged, continuous slow-wave sleep by blocking cerebral H₁ histamine receptors in rats.

Authors:  Masami Ikeda-Sagara; Tomoya Ozaki; Mohammad Shahid; Eri Morioka; Kazuma Wada; Kazuki Honda; Ayana Hori; Yuji Matsuya; Naoki Toyooka; Masayuki Ikeda
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

6.  (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice.

Authors:  Deborah Rudin; John D McCorvy; Grant C Glatfelter; Dino Luethi; Dániel Szöllősi; Tea Ljubišić; Pierce V Kavanagh; Geraldine Dowling; Marion Holy; Kathrin Jaentsch; Donna Walther; Simon D Brandt; Thomas Stockner; Michael H Baumann; Adam L Halberstadt; Harald H Sitte
Journal:  Neuropsychopharmacology       Date:  2021-11-08       Impact factor: 8.294

Review 7.  Good night and good luck: norepinephrine in sleep pharmacology.

Authors:  Heather A Mitchell; David Weinshenker
Journal:  Biochem Pharmacol       Date:  2009-10-13       Impact factor: 5.858

8.  Neural circuitry of stress-induced insomnia in rats.

Authors:  Georgina Cano; Takatoshi Mochizuki; Clifford B Saper
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

9.  Effect of Olanzapine on Clinical and Polysomnography Profiles in Patients with Schizophrenia.

Authors:  Mohammad Zia Ul Haq Katshu; Sukanto Sarkar; S Haque Nizamie
Journal:  Schizophr Res Treatment       Date:  2018-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.